Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02379338 · ClinicalTrials.gov registry record · Phase 1

Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT

A Phase 1 study of Healthy, sponsored by University of Pennsylvania.

Active
Registry status
Phase 1
Development phase
29
Enrollment target
1
Study location

NCT02379338: Active Phase 1 study of Healthy, sponsored by University of Pennsylvania.

NCT02379338 is a Phase 1 study of Healthy that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 29 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02379338, a Phase 1 study of Healthy, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

In this phase 1 pilot study, positron emission tomography (PET/CT) imaging will be used to determine the biodistribution, metabolism and excretion of a novel radiotracer \[18F\]Fluortriopride (\[18F\]FTP).

Primary Outcome

Assessing the biodistribution of the radioactive investigational drug (\[18F\]fluortriopride) and calculation of human dosimetry in healthy volunteers are completed with MRI results from Dynamic Brain cohort, PET/CT results and laboratory results.

Conditions Studied

Healthy

Interventions

  • DRUG [18F]Fluortriopride

Study Locations (1)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2015-01
Est. Completion 2026-08
Phase Phase 1
University of Pennsylvania

1,423 total trials

What the registry record for NCT02379338 still lists

NCT02379338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which [18F]Fluortriopride is the first listed.

NCT02379338 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02379338 about?

NCT02379338 is a clinical study titled "Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT". In this phase 1 pilot study, positron emission tomography (PET/CT) imaging will be used to determine the biodistribution, metabolism and excretion of a novel radiotracer \[18F\]Fluortriopride (\[18F\]FTP).

What is the current status of trial NCT02379338?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2015-01. Estimated completion is 2026-08.

What conditions does trial NCT02379338 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02379338?

The interventions under investigation include: [18F]Fluortriopride (DRUG).

Who is sponsoring clinical trial NCT02379338?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02379338 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02379338's enrollment target sits among peer trials

29 729th of 1090 higher than 356 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02379338, the US trial registry maintained by the National Library of Medicine. NCT02379338 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.